Valuation: Danaher Corporation

Market Cap 134B 118B 109B 102B 190B 12,600B 194B 1,305B 505B 6,216B 502B 491B 21,625B P/E 2026 *
30.1x
P/E 2027 * 24.8x
Enterprise Value 134B 118B 109B 102B 190B 12,600B 194B 1,305B 505B 6,216B 502B 491B 21,625B EV / Sales 2026 *
5.15x
EV / Sales 2027 * 4.74x
Free-Float
71.13%
Yield 2026 *
0.76%
Yield 2027 * 0.81%
1 day+3.83%
1 week+10.02%
Current month+6.71%
1 month+12.80%
3 months+4.16%
6 months-15.37%
Current year-14.85%
1 week 175
Extreme 175
196.74
1 month 169.88
Extreme 169.88
196.74
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap.
05-15Free

Director

2,379 0.0003%
05-15Free

Director

2,379 0.0003%
05-15Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+3.83%+10.02%-3.02%-18.06% 134B
+3.81%+8.84%+23.14%-3.13% 183B
+0.81%-0.89%-22.71%+23.99% 142B
-0.10%-2.01%-57.45%-17.05% 66.08B
+1.23%+3.70%+17.70%+1.23% 51.63B
+0.13%-0.32%-26.93%-32.09% 43.38B
+3.67%+7.39%+15.03%+15.27% 37.18B
+1.30%+5.92%+7.56%+44.94% 36.25B
-0.05%+6.28%-10.02%-15.86% 29.51B
+2.32%+6.58%-22.05%-6.27% 28.38B
Average +1.60%+0.31%-7.88%-0.70% 75.13B
Weighted average by Cap. +2.06%-0.37%-4.72%-0.64%

Financials

2026 *2027 *
Net sales 25.96B 22.86B 21.08B 19.72B 36.95B 2,447B 37.64B 253B 98.14B 1,207B 97.48B 95.37B 4,200B 28.23B 24.85B 22.92B 21.44B 40.17B 2,661B 40.92B 275B 107B 1,312B 106B 104B 4,566B
Net income 4.42B 3.89B 3.59B 3.35B 6.29B 416B 6.4B 43.1B 16.7B 205B 16.58B 16.22B 714B 5.35B 4.71B 4.34B 4.06B 7.61B 504B 7.75B 52.19B 20.22B 249B 20.08B 19.64B 865B
Net Debt - -
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
25/06/26 $196.31 +3.94% 294,877
24/06/26 $188.87 +5.53% 5,646,978
23/06/26 $178.97 +0.44% 4,149,960
22/06/26 $178.19 +0.58% 3,691,892
18/06/26 $177.17 -0.33% 7,258,518
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
188.87USD
Average target price
242.35USD
Spread / Average Target
+28.31%

Quarterly revenue - Rate of surprise